Franklin Biotechnology Discovery Fund Class C
FBTDX
NASDAQ
Weiss Ratings | FBTDX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Reward Grade | C | |||
Risk Index | Fair | |||
Risk Grade | C | |||
Company Info | FBTDX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Provider | Franklin Templeton Investments | |||
Manager/Tenure (Years) | Evan S. McCulloch (27), Akiva Felt (5) | |||
Website | http://www.franklintempleton.com | |||
Fund Information | FBTDX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Fund Name | Franklin Biotechnology Discovery Fund Class C | |||
Category | Health | |||
Sub-Category | Healthcare Sector Equity | |||
Prospectus Objective | Specialty - Health | |||
Inception Date | Mar 04, 2014 | |||
Open/Closed To New Investors | Closed | |||
Minimum Initial Investment | 1,000.00 | |||
Minimum Subsequent Investment | -- | |||
Front End Fee | -- | |||
Back End Fee | 0.01 | |||
Dividends and Shares | FBTDX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield | 0.00% | |||
Dividend | FBTDX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield (Forward) | 0.60% | |||
Asset Allocation | FBTDX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash | 3.95% | |||
Stock | 94.94% | |||
U.S. Stock | 80.49% | |||
Non-U.S. Stock | 14.45% | |||
Bond | 0.92% | |||
U.S. Bond | 0.92% | |||
Non-U.S. Bond | 0.00% | |||
Preferred | 0.19% | |||
Convertible | 0.00% | |||
Other Net | 0.00% | |||
Price History | FBTDX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -1.62% | |||
30-Day Total Return | -3.89% | |||
60-Day Total Return | -2.90% | |||
90-Day Total Return | -7.09% | |||
Year to Date Total Return | -1.14% | |||
1-Year Total Return | -10.46% | |||
2-Year Total Return | 17.91% | |||
3-Year Total Return | 23.42% | |||
5-Year Total Return | 9.91% | |||
Price | FBTDX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Closing Price | -- | |||
1-Month Low Price | -- | |||
1-Month High Price | -- | |||
52-Week Low Price | -- | |||
52-Week Low Price (Date) | -- | |||
52-Week High Price | -- | |||
52-Week High Price (Date) | -- | |||
NAV | FBTDX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Nav | $107.42 | |||
1-Month Low NAV | $107.16 | |||
1-Month High NAV | $114.88 | |||
52-Week Low NAV | $105.48 | |||
52-Week Low NAV (Date) | Jan 14, 2025 | |||
52-Week High NAV | $139.40 | |||
52-Week High Price (Date) | Sep 19, 2024 | |||
Beta / Standard Deviation | FBTDX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.61 | |||
Standard Deviation | 18.56 | |||
Balance Sheet | FBTDX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Total Assets | 780.67M | |||
Operating Ratios | FBTDX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Expense Ratio | 1.80% | |||
Turnover Ratio | 35.87% | |||
Performance | FBTDX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Last Bull Market Total Return | 6.29% | |||
Last Bear Market Total Return | -11.97% | |||